Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SemInERCP
NCT07461389Phase 4Completed
- Sponsor
- CMH Lahore Medical College and Institute of Dentistry
- Start
- Oct 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of simethicone, dicyclomine in intestinal motility disorder, sponsored by CMH Lahore Medical College and Institute of Dentistry. Started Oct 2025; status: completed.
02
Drugs
simethiconedicyclomine
03
Conditions
intestinal motility disorder
Beyond the preview
Go deeper on NCT07461389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07461389.